Skip to main content
Select Search Option
Menu
Weill Cornell Medicine
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach

Wayfinder menu

  • News and Events
  • Directory
  • Cornell University Center for Technology Licensing
Enterprise Innovation
Enterprise Innovation
Explore this Website

Wayfinder menu

  • News and Events
  • Directory
  • Cornell University Center for Technology Licensing
  • Home
  • About Us
    • Leadership
    • Team Directory
    • Annual Reports
    • Contact Us
    • Support Us
  • For Inventors and Innovators
    • Learn About Our Process
    • Connect with Enterprise Innovation
    • Submit Disclosure to Center for Technology Licensing
    • Material Transfer Agreements
    • Inventor Portal
    • Forms and Policies
  • For Industry, Investors and Partners
    • Technology Portfolio
    • Collaboration Opportunities
    • About Our Startups
      • Our Startups
  • Innovation Ecosystem
    • BioVenture eLab
    • Center for Technology Licensing at Weill Cornell Medicine
    • Weill Cornell Medicine in Qatar (WCM-Q)
  • Programs, Offerings and Support
    • Intellectual Property
      • IP and Biotech Due Diligence Workshop
      • Lab to Impact Series: IP Module
    • Expertise and Mentorship
      • CEO Speaker Series
      • Cornell Innovation and Venture Advisors (CIVA)
      • Enterprise Innovation Departmental Liaisons
      • Entrepreneur-in-Residence (EiR) Program
      • Industry Mentors
      • Office Hours
      • Pitch Coaching
    • Credit Bearing Courses and Certificate Programs in Innovation and Entrepreneurship
      • Accelerating BioVenture Innovation (ABI)
      • BioEntrepreneurship Initiative
      • Fundamentals of Academic Business Development
    • Entrepreneurship and Startup Basics
      • Accelerating BioVenture Innovation (ABI)
      • Biomedical Innovation Challenge
      • Capstone Programs and Business Plan Support
      • I-Corps Entrepreneurship Training
      • Lab to Impact Series: Commercialization & Venture Module
      • Startup Symposium & InvestConnect
    • De-risking, Gap and Seed Funding Sources
      • Enterprise Innovation Catalyst Fund
      • Ignite Cornell Lab to Market
      • SBIR/STTR Grant Writing Resources
      • The Gene ’70, MD ’74 and Susan Resnick Prize for Excellence in Entrepreneurship
    • Research and Industry Collaboration Opportunities
    • Medical Device Initiatives
      • 3D Printer Interest Group
      • Computation and Medical Device Interest Group
    • General and Special Interests
      • Dean’s Symposium on Innovation
      • Lab to Impact Series: Health Module
    • Additional Resources for Aspiring Innovators and Entrepreneurs
      • Invent Together
      • LifeSci NYC Internship Program
    • Partnership in Innovation and Entrepreneurial Education
      • BioDesign Series – Engineering Summer Program (ESP)
      • Advancing Cornell Career Experiences for Science Students (ACCESS)
      • Eclectic Convergence, Cornell Entrepreneurship Summit
    • Learning Library
  • News and Events
    • Events
    • Past Events
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
  • Home
  • About Us
  • For Inventors and Innovators
  • For Industry, Investors and Partners
  • Innovation Ecosystem
  • Programs, Offerings and Support
  • News and Events
  • Home
  • For Industry, Investors and Partners
    • Technology Portfolio
    • Collaboration Opportunities
    • About Our Startups

Technology Portfolio

     

Novel Target and Inhibitors for prevention and treatment of Tuberculosis

Modulating Adenylyl Cyclase for the Treatment of Bacterial or Eukaryotic Infections

siRNA Agents that Reduce Tumor Growth and Angiogenesis

p21 Inducers as Neuroprotective and Anticancer Agents

Compounds that Induce Arginase 1 to Enhance Neuroprotection

Blocking Leukocyte Migration and Inflammation with Antibodies

Predicting and Treating Cancer Metastasis Before the Formation of Pre-metastatic Clusters

Use of Dabco-Based Compounds as Potassium Channel Blockers and Openers

Chemical Inhibitors of Soluble Adenylyl Cyclase (sAC)

Purine Receptor P2Y Modulators as CNS Therapeutics and In Stem Cell Maintenance and Differentiation

  • « first
  • ‹ previous
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10 (current)
  • 11
  • next ›
  • last »
Our Location
Enterprise Innovation
Contact Us
  • Twitter
  • LinkedIn
Enterprise Innovation
1155 York Ave.
New York, NY 10065
Phone: (646) 962-7045
  • About Us
    • Leadership
    • Team Directory
    • Annual Reports
    • Contact Us
    • Support Us
  • For Inventors and Innovators
    • Learn About Our Process
    • Connect with Enterprise Innovation
    • Submit Disclosure to Center for Technology Licensing
    • Material Transfer Agreements
    • Inventor Portal
    • Forms and Policies
  • For Industry, Investors and Partners
    • Technology Portfolio
    • Collaboration Opportunities
    • About Our Startups
  • Innovation Ecosystem
    • BioVenture eLab
    • Center for Technology Licensing at Weill Cornell Medicine
    • Weill Cornell Medicine in Qatar (WCM-Q)
  • Programs, Offerings and Support
    • Intellectual Property
    • Expertise and Mentorship
    • Credit Bearing Courses and Certificate Programs in Innovation and Entrepreneurship
    • Entrepreneurship and Startup Basics
    • De-risking, Gap and Seed Funding Sources
    • Research and Industry Collaboration Opportunities
    • Medical Device Initiatives
    • General and Special Interests
    • Additional Resources for Aspiring Innovators and Entrepreneurs
    • Partnership in Innovation and Entrepreneurial Education
    • Learning Library
  • News and Events
    • Events
    • Past Events
Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists.
Weill Cornell Medicine
© Weill Cornell Medicine.
  • Privacy & Legal
  • Equal Education & Employment
  • Careers
  • Giving
  • Directory
  • Web Accessibility Assistance